BioMAS

BioMAS

BioMAS (Biotechnologies and Advanced Modeling for Sustainable Health) is a transversal, interdisciplinary research team within the IMS laboratory. It aims to develop innovative biotechnologies and bio-inspired models to better understand chronic diseases (e.g. neurological disorders, cancer, diabetes), identify biomarkers, simulate therapeutic responses, and personalize healthcare, as well as environmental health and exposure assessment. BioMAS promotes ethical, sustainable, and adaptable solutions, aligned with global health challenges and open to the integration of other diseases and emerging technologies.

Read more

Integrated Approaches for Sustainable and Personalized Healthcare

BioMAS addresses key public health challenges through a transversal, interdisciplinary strategy, as part of the ACTES initiative (Action Transverse Émergente d’Enjeu Sociétal).

BioMAS aims to overcome current therapeutic limitations by integrating advanced biotechnology, innovative algorithms and computational models based on experimental data to identify key biomarkers, simulate therapeutic responses, develop medical monitoring devices and automated care administration. The goal is to offer more accurate, less invasive healthcare solutions tailored to each patient, while complying with strict ethical standards and minimising the environmental footprint. BioMAS also contributes to environmental health by developing tools capable of detecting and monitoring pollutants that may affect human health and the ecosystem.

The project promotes adaptive, patient-centered diagnostics and treatments aligned with the United Nations Sustainable Development Goals, particularly health and well-being (Goal 3) and sustainable communities (Goal 11).

Scientific and Technological Objectives for BioMAS

Current medical solutions, often reliant on expensive and non-sustainable materials, face significant limitations. The BioMAS project addresses these issues through an interdisciplinary approach to complex non-communicable diseases (neurological, cancer, diabetes, cardiovascular). Its goals include:

1) Deciphering biological mechanisms to enable targeted, personalized therapies;

 2) Identifying and monitoring biomarkers for precise, less invasive diagnostics;

 3) Developing advanced modeling (e.g., digital twins) to simulate responses and reduce animal testing;

 4) Translating innovations into clinical applications, while reducing environmental impact via biosourced materials and sustainable technologies.

Implementation: BioMAS Project Methodology

In a collaborative and interdisciplinary framework, the targeted contributions range from i) the design of a new generation of selective sensors for specific biomarkers, ii) the development of bio-inspired dynamical models to recreate, in silico, living behaviours, and iii) the design of robust control algorithms to blood glucose regulation of patients with diabetes (as part of daily home care, but also in a hospital environment) to name a few.

The aim of Axis 2 is to develop approaches for precision oncology, with a focus on non-invasive and personalized monitoring and treatment of cancer. This axis is based on interdisciplinary work combining micro- and nanotechnologies, sensing technologies, advanced algorithms, and biomedical modeling, within a translational research context. By integrating sensing, modeling, and data analysis, Axis 2 aims to improve therapeutic monitoring and support the development of more effective precision oncology solutions.

The aim of this axis is to develop therapeutic or assistive strategies capable of neuromimetic interaction with neural tissue and operating under closed-loop control architectures, allowing adaptive personalization to the patient, the pathology, and its chronic evolution.

This research focus aims to design integrated modeling, sensing, and bio-hybrid instrumentation frameworks for cardiovascular, respiratory, and neurocardiac systems, combining multi-scale physiological modeling, data-driven approaches, and closed-loop control to enable personalized diagnosis, prognosis, digital twins, and electroceutical therapies.

Axis 5 develops approaches for monitoring environmental exposures and their impact on human and animal health. It focuses on chemical pollutants and electromagnetic exposures and their links with chronic diseases, aging, and biodiversity. Combining portable sensors, exposome biomarkers, multivariate data analysis, and modeling, it supports public health assessment, exposure recommendations, and understanding of environmental risks.

BioMAS Cross-disciplinarity

Waves Signal & Image Automatic control Bioelectronics Circuit design Organic electronics Living platform Go to page
Living platform
Go to page
Waves
Signal & Image
Automatic control
Bioelectronics
Circuit design
Organic electronics

BioMAS skills

Biotechnology

Multiphysics sensor

Lab-on-chip

Therapeutic and diagnostic systems ​

Virtual Human Twin

Advanced biomedical research

Sustainable electronics

Electroceuticals

Organoïd

Advanced modeling

Multiple drug control

Translational research

Partners

Collaborations and partners

BioMAS research team brings together the expertise of several researchers from six research groups at the IMS laboratory. This cross-disciplinary initiative is organized around six work packages, each led by two permanent researchers affiliated with BioMAS. It is also based on five working groups corresponding to the five thematic areas defined in the initial roadmap. BioMAS develops its activities in close collaboration with other laboratories at the University of Bordeaux (CBMN, LCPO, I2M, IINS, NeuroCampus, etc.), the Bordeaux University Hospital, and within the framework of collaborative projects funded by the University of Bordeaux, the French National Research Agency (ANR), the European Union, as well as international programmes involving countries such as Japan and Singapore.

Local collaborators

National collaborators

European collaborators

International collaborators

Energy_Partners_IMS Bordeaux

Energy sector

BioMAS publications

VOSviewer / Keyword co-occurrence clustering view generated with a minimum occurrence threshold of 6 for the last 5 years and refreshed every 6 months using data sources from Scopus
VOSviewer / Keyword co-occurrence clustering view generated with a minimum occurrence threshold of 6 for the last 5 years and refreshed every 6 months using data sources from Scopus
Scientific production by country (last 5 years, refreshed every 6 months). The map was generated through "Biblioshiny", different shades of blue indicate different productivity rate (dark blue = high productivity, grey = no articles)
Scientific production by country (last 5 years, refreshed every 6 months). The map was generated through "Biblioshiny", different shades of blue indicate different productivity rate (dark blue = high productivity, grey = no articles)

Ongoing projects

Members

Staff

Meet the members of the BioMAS cross-disciplinary group

Mamatimin ABBAS
Mamatimin ABBAS
Tudor-Bogdan AIRIMITOAIE
Tudor-Bogdan AIRIMITOAIE
Jérôme CIESLAK
Jérôme CIESLAK
Shreyas Sureshrao DESHPANDE
Shreyas Sureshrao DESHPANDE
Ludivine FADEL
Ludivine FADEL
Rémi GIRAUD
Rémi GIRAUD
David GUCIK-DERIGNY
David GUCIK-DERIGNY
Célia GUTIERREZ
Célia GUTIERREZ
Hamida HALLIL ABBAS
Hamida HALLIL ABBAS
Florian KOLBL
Florian KOLBL
Timothée LEVI
Timothée LEVI
Annesha MAZUMDER
Annesha MAZUMDER
Rosa ORLACCHIO
Rosa ORLACCHIO
Emilie PINET
Emilie PINET
Antoine PIROG
Antoine PIROG
Florence POULLETIER DE GANNES
Florence POULLETIER DE GANNES
François RIVET
François RIVET
Damien THUAU
Damien THUAU
Stéphane VICTOR
Stéphane VICTOR
Résumé en français

En s’appuyant sur des compétences scientifiques pluridisciplinaires au sein d’une unité de recherche à la convergence de l’ingénierie, de la santé numérique et de la biotechnologie, BioMAS mobilise des biotechnologies avancées, des algorithmes innovants et des modèles numériques basés sur des données expérimentales pour : identifier des biomarqueurs clés, simuler des réponses thérapeutiques, développer des dispositifs de suivi médical et automatiser l’administration de soins. L’objectif est de proposer des solutions de santé plus précises, moins invasives et adaptées à chaque patient , tout en respectant des normes éthiques strictes et en minimisant l’empreinte écologique. BioMAS contribue également à la santé environnementale, en développant des outils capables de mesurer et analyser l’exposition aux polluants chimiques et aux ondes électromagnétiques.

BioMAS s’inscrit dans le cadre des Objectifs de Développement Durable de l’Organisation des Nations Unies et vise à positionner le laboratoire IMS comme un acteur clé des initiatives de recherche collaborative à l’échelle locale, nationale, européenne et internationale. En combinant innovation, durabilité et expertises scientifiques, BioMAS aspire à transformer les découvertes fondamentales en solutions concrètes pour améliorer la qualité des soins et le bien-être des populations, tout en intégrant la dimension environnementale dans ses approches.

Contact our team

If you have a request or questions about the laboratory, please contact our team.